Glioma segmentation models used in multiparametric MRI for treatment planning can pose significant patient safety risks if they fail to accurately identify critical sub-regions. Traditional metrics such as Dice scores are insufficient to detect these errors. Researchers have investigated the use of Monte Carlo (MC) Dropout to estimate voxel-level uncertainty in segmentation models, but its reliability in identifying segmentation errors is questionable. The method's confidence measures do not necessarily translate to reliability, highlighting a critical gap in current evaluation approaches1. This limitation is particularly concerning in medical imaging applications where accuracy is paramount. The inability to detect silent failures in segmentation models can have severe consequences for patient outcomes. As a result, practitioners must reexamine their reliance on MC Dropout and explore alternative methods for uncertainty estimation to ensure the accuracy and reliability of glioma segmentation models, which is crucial for effective treatment planning and patient safety.
Confidence is Not Reliability: Rethinking MC Dropout in Brain Tumour Segmentation
⚡ High Priority
Why This Matters
A segmentation model that fails silently on treatment-critical sub-regions represents a patient safety risk that overlap-based metrics such as Dice scores cannot expose.
References
- Authors. (2026, June 17). Confidence is Not Reliability: Rethinking MC Dropout in Brain Tumour Segmentation. arXiv. https://arxiv.org/abs/2606.19300v1
Original Source
arXiv ML
Read original →